People dumping. No news that I can find.

Could Scott Silverman be unloading another 2 million shares?

Very large seller in the .11-.115, When he is taken out PSID should fly. JMO

What's up with YOUTT, selling over 540,000 shares and it seems on a regular basis. New to this board so if there has been a posting on this allready I appologize. Pat

December 23, 2011 at 9:35 am

SCOLR Pharma, Inc. Announces Initial Shipments of its Nutritional Products

BOTHELL, Wash. , Dec. 23, 2011 /PRNewswire/ — SCOLR Pharma, Inc. (OTCQB: SCLR.OB - News) today announced that it has received and shipped initial retail orders for its extended-release nutritional products based on the Company’s proprietary CDT® oral drug delivery platform. The shipments represent SCOLR’s first significant direct retail sales of its nutritional products. Stephen J. Turner , SCOLR Pharma’s President and CEO, said, “Shipment of these initial orders marks an important milestone for SCOLR as we continue to focus on growing our nutritional products business into a sustainable source of revenue. We are gratified by the response we have had with retailers and confident that our products are greeted well by consumers.”

Turner said SCOLR intends to provide investors with future updates on its nutritional business activities in conjunction with its quarterly announcements of financial results and in its periodic reports filed with the Securities and Exchange Commission.

About SCOLR Pharma:

Based in Bothell, Washington , SCOLR Pharma, Inc. is a specialty pharmaceutical company focused on applying its formulation expertise and patented CDT platforms to develop novel prescription pharmaceutical, over-the-counter (OTC), and nutritional products. Its CDT drug delivery platforms are based on multiple issued and pending patents and other intellectual property for the programmed release or enhanced performance of active pharmaceutical ingredients and nutritional products. For more information on SCOLR Pharma, please call 425-368-1050 or visit http://www.scolr.com/.

February 15, 2012 at 11:24 am

SCOLR Pharma’s Partner to Commence Bioequivalence Study of Ondansetron

BOTHELL, Wash., Feb. 14, 2012 /PRNewswire/ — SCOLR Pharma, Inc. (OTCQB: SCLR.OB - News) announced today that RedHill Biopharma Ltd., a license partner that had previously obtained the exclusive worldwide rights to use SCOLR’s patented technology to develop a new version of ondansetron, will conduct a bioequivalence trial in Canada. Both the US Food and Drug Administration (FDA) and Health Canada have reviewed the protocol for the study and have no objections.

RedHill submitted an Investigational New Drug application (IND) to the FDA and a Clinical Trial Application (CTA) to Health Canada seeking permission to compare the bioequivalence of its product, which it calls RHB-102, to Zofran® (ondansetron), which is manufactured by GlaxoSmithKline. Zofran® is an anti-emetic drug (i.e. for prevention of nausea and vomiting) that is administered several times per day. RHB-102 is a once-daily controlled release tablet formulation of ondansetron, a serotonin 5-HT3 receptor antagonist.

RedHill Biopharma said publicly, based on advice received from its regulatory consultants, that subject to certain conditions, the study may be considered a pivotal trial (Phase III-equivalent) that may be used by the Company for a marketing application to the FDA. RedHill Biopharma estimated the development costs of RHB-102, until submission of an application to the FDA, will total $2-3 million.

Stephen Turner, President and CEO of SCOLR, said: “We believe that the RedHill Biopharma announcement again affirms the potential value of SCOLR’s patented technology in developing new pharmaceuticals that improve on existing drugs. We look forward to a successful outcome on this study and a promising ongoing relationship with RedHill.”

About SCOLR Pharma:

Based in Bothell, Washington, SCOLR Pharma, Inc. is a specialty pharmaceutical company focused on applying its formulation expertise and patented CDT® platforms to develop novel prescription pharmaceutical, over-the-counter (OTC), and nutritional products. Its CDT® drug delivery platforms are based on multiple issued and pending patents and other intellectual property for the programmed release or enhanced performance of active pharmaceutical ingredients and nutritional products. For more information on SCOLR Pharma, please call 425-368-1050 or visit http://www.scolr.com/.

About RedHill Biopharma Ltd.:

RedHill Biopharma is an emerging Israeli biopharmaceutical company focused primarily on development and acquisition of late clinical-stage new formulations of existing drugs. The Company’s current product pipeline includes a once-daily formulation of a leading congestive heart failure and high blood pressure drug, a once-daily formulation of a leading radiotherapy induced nausea and vomiting prevention drug, an oral thin film formulation of a leading triptan for the treatment of acute migraine, a combination therapy for the treatment of MAP infection in Crohn’s as well as a companion diagnostic test for detection of the MAP bacteria, a combination treatment of resistant H. pylori bacteria causing ulcers, and a patent protected encapsulated formulation for bowel preparation ahead of certain gastro procedures. The Company’s team includes prominent pharmaceutical experts. For more information please visit: www.redhillbio.com.

I thought this would be a great time to start a new board for SCLR since the company is also starting to become a revenue generating business.
Not only are we finally starting to sell our nutraceauticals in large retailers, but I have been informed that we are also getting re-orders. It's taken a long time to get here, but let's hope that SCLR has arrived and will grow from here.

Is HEPI still selling proalgazyme. I went online and searched for sellers and have not found any?

NEWS...

Universal Potash Mobilizes Onsite Staking and Access Recon.

Mar 31, 2011 01:45:00 (ET)


FOX ISLAND, Wash., March 31, 2011 /PRNewswire via COMTEX/ -- Universal Potash Corporation (the "Company") (pinksheets:UPCO) announces staking has commenced on our interests in the Paradox Basin of Utah. Harrison Land Services has been contracted by UPCO to commence the recon phase for two drill hole locations situated within the newly acquired leases. The recon phase will include staking, flagging, photographing and mapping of the two proposed drill site locations. Photos will be available on our website at www.UniversalPotash.com . This Phase 1 process will set the foundation for Universal Potash's baseline data accumulation, which is required for carrying out the necessary environmental surveys to implement the regulatory process. Universal Potash Corp. anticipates the turnaround time for the permit approval from Utah State Trust Lands to be four to six weeks.

The Universal Potash Corp. exploration planning process is nearing completion. Detailed logistics are currently being incorporated into our exploration model. Contractors, excavation and reclamation experts, drilling and mud engineering companies are preparing final budgets and cost associations with our exploration project. Universal Potash Corp's newest venture is located less than 1,000 yards west of the BLM's designated KPLA (Known Potash Leasing Area) reserve. The UPCO property interests encompass nearly 2,000 acres of the School and Institutional Trust Lands Administration (SITLA) subsurface potassium rights near the Lisbon Valley KPLA.


Investor RelationsToll Free 1-877-331-8777

SOURCE Universal Potash Corporation

Huge volume early. I wish I could figure out what's going on here. Usually volume preceeds price.

Doog... Is that why we have a lid on UPCO at 17-20 cents?

Someone's unloading big time. Glad to see that there are also a lot of buyers.

Look at the price of the shares that we are giving as we borrow.... 15 cents and warrants at .25 cents. That should put a floor under the price of the shares in the short term. I don't understand why people are giving them away. JMO

"Under the terms of the agreement, Universal Potash has the right to call upon funds as needed. UPCO has received its first tranche which will be used for additional claim evaluations and operating expenses. United Potash Corp may draw up to $1,000,000 in total by issuing units consisting of one share of its common stock at $0.15 US and one common stock purchase warrant exercisable for the purchase of one additional share of common stock at $0.25 for the first 12 months and $0.50 if exercised by the end of the second year. The securities to issued under the agreement have not been registered under the Securities Act of 1933 and may not be offered or sold in the United States absent a registration or an applicable exemption from the registration"

GOOD News....

Universal Potash Commences Paradox Basin Exploration Program

Mar 28, 2011 01:00:00 (ET)


FOX ISLAND, Wash., March 28, 2011 /PRNewswire via COMTEX/ -- Universal Potash Corporation (the "Company") (UPCO, Trade ) announces the immediate start-up of our Potash Exploration Program focused on our interests in the Paradox Basin of Utah. Universal Potash Corp's newest venture is located less than 1,000 yards west of the BLM's designated KPLA (Known Potash Leasing Area) reserve. The UPCO property interests encompass nearly 2,000 acres of the School and Institutional Trust Lands Administration (SITLA) subsurface potassium rights near the Lisbon Valley KPLA and indicates multiple potash depths due to their proximity to the flank of the Lisbon anticline. "Our timing couldn't be better. Financing is available in the markets and Universal Potash is positioned to take advantage of this timing with our proposed first 2 site development on the three square mile lease interests adjacent to Lisbon Valley, Utah," stated Kevin M. Murphy, CEO of Universal Potash Corp.

"We favor Potash....." stated Goldman Sachs Spokesman

"We favor potash among the three nutrients (nitrogen, potash and phosphate), given more robust demand prospects and a continued tight supply backdrop in the intermediate term," said Goldman Sachs in its statement. The stocks of potash producers are predicted to outshine those of more nitrogen focused companies, due to what brokerage firm Goldman Sachs calls "peaking corn prices." In a statement issued this past Monday, Goldman Sachs noted that the current corn price of $6 to $7 per bushel is unsustainable. "Increasing global corn supplies, falling demand for feed and diminished political enthusiasm for ethanol in the U.S. will combine to lower corn prices by 2012," said Goldman. The price of nitrogen has a closer connection, compared to potash, to the price of corn; therefore, Goldman Sachs announced that it favored fertilizer producers tied to potash, rather than nitrogen.

UPCO Phase1 Drill Site And Access Recon

Harrison Land Services has been engaged by UPCO to carry out an extensive evaluation that will target the best drill sites and access to the 3 newly acquired Potash exploration lease blocks immediately west of Lisbon Valley anticline of the Paradox Basin. Analysis of our target drill sites will be based on a combination of criteria that will result in the leastdisturbance areato the environment by the drill pad locations, access to sites that best fit geologicfavorability for Potash discovery and avoidance of cultural, paleo and biological resources.

HLS willattempt to avoid, as much possible, the need for a federal right of way, which will eliminate extensive turnaround times, save on permitting and 3rd party survey costs. HLS will stake centerline of the access corridor as well as drill site center peg with photos, which we will post on the UPCO Website at www.UniversalPotash.com

UPCO Phase2 Exploration Plan & NOI / ROW submission

Research and implementation of our second phase will commence simultaneously with the preparation of our exploration plan. UPCO's plan will includeexploration maps, pad, pits and accessdimensions, disturbance areacalculations, proposed action document, pad diagrams, hole diagrams and operations list, generation of the Notice Of Intent (NOI) application and submitthese generateditemsto SITLA or Bureau of Land Management (BLM) if a federal Right Of Way (ROW) is required. As part of the exploration planning, HLS will find sources forwater, drill fluid disposal and countyroad encroachment and pay necessary filing fees.

About Universal Potash Corp:

Universal Potash Corp. is an acquisition driven exploration company, dedicated to increasing shareholder value. The Management of Universal Potash's principal focus is the acquisition of premium leaseholds and the future development of these properties and business interests on a global basis. Management efforts are channeled into building Universal Potash Corp. into an international enterprise and meeting the growing challenge of feeding the world.

"Safe Harbor" Statement: Under The Private Securities Litigation Reform Act of 1995: The statements in all press releases that relate to the company's expectations, with regard to the future impact on the company's results from new projects in development, are forward-looking statements. A complete disclosure of our "SAFE HARBOR "statement is posted on our website at www.UniversalPotash.com under the heading "NEWS." The quotes attributed to and by Goldman Sachs are not to be considered and endorsement of, or recommendation to buy Universal Potash Corp.

CEO@UniversalPotash.com e-mail address is being protected from spam bots. You need JavaScript enabled to view it.

Investor RelationsToll Free 1-877-331-8777

SOURCE Universal Potash Corporation

Gm all. Doog....do you know if the company has borrowed any of the money from the fund raising they did? Did they take it all? Not sure if it is like a line of credit or investment? TIA, Pat

What do you think doog? Are we going to take it out. Lots of volume today but there are still a lot of sellers.

Huge volume early and nice price movement. Will we break out?

Do you mind if I ask you why?

I don't know what will drive the share price down that low. We have a good base around .13 cents. I would not expect bad news in the near future. Therefore, the people who are selling are those upset that we are not breaking out above .22 cent resistence.

I know I'm being impatient doog. :)

I wish I could figure out what's going on. A lot of selling and overhead supply. There is also a lot of buying and the price is holding up. My estimate is that it will take some potent news to get UPCO through the 22 cent area. JMO I wish DOOG or stevo would give theirs about now.

Highest weekly volume ever and no movement is not good. We'll have to wait and see what next week brings. A lot of people taking profits from earlier buys.

stevo...you have not had much to say. Disappointed???

A lot of profits being taken here. I wonder if we will get through this resistense without more good news.

Definitely know what you mean. I bought UPCO at from .14 to .15 because news was shortly coming out and then saw it trade down to .11.

I may have spoken to soon. Now we are getting volume and the price seems to be inching up at .165. Volume preceeds price and hopefully news.

You never know greenD. Lot of volume today already and someone gave it away below .12 That seems to happen in UPCO. Give it a shot.

It appears that we are getting some interrest in UPCO today. Price and shares purchased. This stock would move if we could get some news.

I'm with you Stevo. If I knew when the news was coming out (much later than I was told right now), I would be jumping all over UPCO at this price. JMO

Getting some nice volume and a little upward price movement today. I hope this means some news is coming out shortly.

Unfortunately Doog your not correct. If we don't get some news real quick, we'll be back down to 5 cents again.

Goog and Stevo, I understand that this will take a little time to play out, but still looks very good. Do you agree?

It looks like others have less patience then I do. Anyone know how long it takes to report results of auctions?

So I find out today that the guy who put me in UPCO, no longer works at the place he did when he reccomended it. :)

Doog and Stevo....my problem is not with you. You obviously are expecting excellent news as I am. My problem, and I am a VERY patient investor, was what I was told when I invested in UPCO. It is taking much longer to get the news then what I was told. I also want to point out that there is a lot of overhead resistence above 20 cents, plus the profit taking that will ensue as the price moves up, from those investors that bought at much lower prices. I am fine with all that because I will be showing a nice profit also. As I evaluate the news that is released, I will be in a better position to be able to know what kind of long term prospects the company has. JMO

My patience is long gone. I was told that UPCO would be at .20 cents 3 weeks ago with all the great news that was coming out.

I just can't beleave the buying panic that's going on. :}

Just love it. Let's see. PR Release ....down for the day. I just can't wait fo more Pr's. :)

Does not look good to me. I hate to be a negative voice but looks like this could be a pump and dump. Lots of volume and no movement. JMO and beleive me I want this to move.

People getting tired of waiting for THE NEWS to come out. If there is news what's holding them up from putting it out?